In sickle cell disease, what is the primary focus in management of an acute chest syndrome?

• A. Immediate exchange transfusion in all cases
• B. Ensure adequate oxygenation, aggressive hydration, analgesia, and antibiotics as indicated
• C. Avoid hydration to prevent volume overload
• D. Corticosteroids are the only therapy

Answer: (B)

The main idea here is that acute chest syndrome in sickle cell disease is treated with early, broad supportive care aimed at stopping the sickling process and preventing respiratory decline. Keeping oxygen levels up is essential because low oxygen drives red blood cell sickling and worsens lung injury; giving supplemental oxygen helps maintain adequate gas exchange and reduces the tendency for vessels to constrict in the lungs. Hydration matters too because it lowers blood viscosity and improves perfusion, which supports better oxygen delivery to tissues and reduces the conditions that promote sickling. Pain control is crucial because severe chest and back or abdominal pain can lead to shallow breathing and atelectasis, so effective analgesia encourages deep breaths, coughing, and lung clearance. If an infection is suspected or cannot be ruled out, antibiotics are added since infections can trigger or worsen ACS and timely treatment improves outcomes.

While some cases may require more intensive interventions, immediate exchange transfusion in all cases is not standard practice. It’s reserved for severe or deteriorating ACS when optimized supportive care isn’t enough. Hydration is not something to avoid; rather, adequate fluids are part of the plan unless there are fluid overload concerns. Corticosteroids are not used as the sole or first-line therapy for ACS due to limited consistent benefit and potential adverse effects.